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Precisely defining the roles of specific cell types is an intriguing and challenging frontier in the
study of intact biological systems, and has stimulated the rapid development of genetically-
encoded observation and control tools. However, targeting these tools with adequate specificity
remains challenging: most cell types are best defined by the intersection of two or more features
such as active promoter elements, location, and connectivity. Here we have combined
recombinase tools with engineered introns to achieve expression of genetically-encoded payloads
conditional upon multiple cell-type features, using Boolean logical operations all governed by a
single versatile vector. We use this approach to target intersectionally-specified populations of
inhibitory interneurons in mammalian hippocampus and neurons of the ventral tegmental area
defined by both genetic and wiring properties. This flexible and modular approach may expand the
application of genetically-encoded interventional and observational tools for intact-systems
biology.
Introduction
Understanding how defined cell types contribute to organism function is a central goal in
biology, and an acute challenge for neuroscience1. Recent development of optically-
modulated, genetically-encoded tools for testing necessity and sufficiency of precise activity
patterns2,3 has enabled the causal linkage of neuronal activity to circuit dynamics and
behavior, but these tools are only as good as their targetability within intact systems. Cell
types4 defined by gene-expression pattern are targetable via either transgenic or viral
approaches. While genetically specific, the transgenic approach (inserting genes into defined
loci to recapitulate native expression patterns) requires a new animal strain to be generated
for each tool. In contrast, viruses are rapidly adaptable, with flexibility in tool payload and
injection location. However, suitable promoter fragments (to drive expression of genetically-
encoded tools) must be short, strong, and specific; the viral capsid determines packaging
efficiency and limits this strategy3. Recent approaches have combined the versatility of viral
intervention with fuller genetic-specificity conferred by the native chromosomal
environment by pairing recombinase-dependent viruses with recombinase-expressing animal
lines5-10.
While elegant, these approaches define cell types by only a single feature. Moreover, cells
identical by one marker may serve different or even oppositional roles in physiology or
behavior. Therefore there is strong motivation to enable multiple-feature definition,
including multiple genetic as well as wiring features. A versatile viral system for defining
cell types based on multiple features4 with only a single nontoxic virus (such as AAV or
lentivirus) would powerfully enhance opportunities arising from development of control and
observational tools. Targeting cells based on multiple genetic factors generally requires
crossing transgenic animals expressing multiple recombinases with animals that express a
gene only after recombinase-dependent excision of multiple STOP cassettes11. This method
has yielded insights into development, but is less scalable and flexible than a viral approach,
and is further complicated by transient developmental promoter activity (triggering
expression of recombinases), potentially leading to tool expression in off-target adult
populations. Viral delivery in the adult would solve this temporal dilemma, but is limited by
viral payload limits3 and the large size of STOP cassettes. Elegant approaches to logical
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gene expression using serine integrases have been described in vitro12, but do not utilize
recombinases typically built into transgenic mammals, and promoter manipulation strategies
used in this approach can be leaky in vivo as we show (below). Another approach splits
proteins in two pieces, which are separately expressed; functionality results only in cells
expressing both pieces. While some function is generated with bacteriorhodopsin13,
channelrhodopsins are poorly expressed this way14; more importantly, construction of such
an effector protein-specific targeting approach may not be rapidly adaptable to new tools.
Here, we have created a versatile single-AAV system for selective expression conditional
upon multiple cell-type features using Boolean logical operations. We validate specificity
and potency of the system (which involves custom-modified intronic sequences and diverse
recombinases) by expressing opsins and fluorescent proteins both in vitro and in vivo within
populations defined either positively or negatively by multiple genetic or wiring features.
Designed for use with broadly available tools, this system is termed INTRSECT, for
INTronic Recombinase Sites Enabling Combinatorial Targeting.
RESULTS
Diversifying the single-recombinase-dependent AAVs
We first sought to expand the DIO (double inverted open-reading-frame) Cre-dependent
expression system5-8 by developing conditional-expression vectors dependent upon
additional recombinases. We used a mouse-optimized version of Flp15 which has been
applied extensively in Drosophila4, and we synthesized a human-codon optimized version of
phage-derived Dre16. Cre, Flp, and Dre recognize short sequences (Lox, FRT, and Rox sites,
respectively) that share a standard structure conferring both identity (sites with different
spacer sequences cannot recombine) and directionality (sequence between two sites in the
same direction is excised; sequence between sites in opposite directions is inverted; Fig. 1a).
The DIO strategy uses both excision and inversion5-8. The targeted gene is initially anti-
sense relative to the promoter, preventing functional transcription. This inverted sequence is
flanked by two pairs of incompatible recognition sites (e.g. loxP and lox2722); two
successive recombination events lock the targeted gene into the forward orientation (Fig.
1b). To create Flp- and Dre-dependent DIOs (fDIO and dDIO), we used two FRT sites (FRT
and F517) and since only one Rox site was known, we created a novel site (Rox2) by
modifying the Rox16 spacer (Fig. 1a).
We investigated functionality and specificity of these DIOs in vitro using channelrhodopsin
(ChR2)-eYFP as a payload. HEK293 cells were transfected with each DIO alone, or also
with each recombinase, and analyzed for fluorophore expression using flow cytometry (Fig.
1c,d). To quantify the results, we assessed whether the data was better fit by a single curve
(indicating a uniform population of eYFP negative cells) or by multiple curves (indicating
mixed eYFP positive and negative cells; see Methods). All DIOs in isolation had expression
levels comparable to the negative control. When cotransfected with the correct recombinase,
all DIOs had robust expression (Fig. 1d). Notably, Cre and Dre exhibited cross-reactivity
(Fig. 1c,d; arrowheads), while Flp and fDIO were independent of cDIO/dDIO and Cre/Dre
respectively.
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To test in vivo functionality, we co-injected viruses encoding each DIO-ChR2-eYFP and
each recombinase into mouse hippocampus (Fig. 1e). All DIOs had virtually no leak in
isolation and strong expression with the correct recombinase (Fig. 1f,g). Cross-activation
was observed in vivo between dDIO-ChR2-eYFP and Cre (Supplementary Fig. 1), but not
Dre and cDIO-ChR2-eYFP. ChR2 stimulation in vivo evoked strong activity in all cases
(Fig. 1h).
Development of a Cre AND Flp-dependent construct
With the goal of targeting based on multiple features, we first paired Cre and Flp (chosen for
lack of detectable cross-reactivity and for increasingly-available driver lines) to
independently control relative directionality of the promoter and open reading frame (ORF;
Supplementary Fig. 2a-d; also see12), but observed inappropriate expression in vivo. The
second strategy used nested recombinases to manipulate separate domains of the ORF
(Supplementary Fig. 3e-i), but suffered from low expression.
Next, we considered that introns, present in DNA but excised during mRNA processing at
conserved exon-intron boundary sequences18,19, could allow for insertion of recombinase
machinery directly into the gene without affecting the protein product. We first tested
whether introns introduced into ChR2-eYFP would degrade protein functionality and if
insertion of recombinase recognition sites into introns would impair splicing. We identified
intron insertion sites that naturally mimic exonic splice sequences18,19 near the middle of
each ORF, such that individual exons would be unlikely to encode functional protein. We
inserted two introns: intron B from cytomegalovirus IE120 (‘intron 1’; 112bp) into ChR2 or
intron 3 from mouse IgE21 (‘intron 2’; 82bp) into eYFP, either in native form or with
addition of a lox2722 (‘+lox’) site within regions not likely to function in splicing. We also
created a construct containing both introns (Fig. 2a).
HEK293 cells transfected with any of these constructs expressed eYFP, suggesting proper
splicing. cDNAs amplified from expressing cells and the source DNA were amplified by
PCR using primer sets that spanned single introns (Fig. 2b) or both introns (Supplementary
Fig. 4a). We noted variability in the size of the amplicon from the DNA template, whereas
cDNA bands were uniform, further suggesting proper splicing. Upon sequencing, introns
were absent from all cDNAs synthesized with primers spanning a single intron (Fig. 2c) or
spanning both introns (except intron 1+lox, suggesting altered splicing in this modified
intron; Supplementary Fig. 4b). To assay ChR2 function, we transfected neuronal cultures
(Fig. 2d) and obtained patch-clamp recordings (Fig. 2e). Photocurrents were comparable to
native ChR2-eYFP except for intron 2+lox photocurrents, which were larger (ChR2-eYFP:
1422±92 pA n=19; intron 2+lox: 2279±247 pA n=5, p<0.01). Neither exon fragment of
ChR2 was able to generate photocurrents in isolation (Supplementary Fig. 5). Finally, to
assay these constructs in vivo, we injected lentivirus into mouse prefrontal cortex (mPFC).
All constructs expressed by 1 week, and sustained expression through at least 4 weeks (Fig.
2f, Supplementary Fig. 6). Together, these results indicate that short introns inserted into the
ChR2-eYFP coding sequence are properly spliced, do not impair gene function, and enable
addition of heterologous sequence to the reading frame.
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We next sought to optimize intron 1 given impaired performance relative to intron 2. We
identified differences between intron 1 and the consensus splice sequence18,19
(Supplementary Fig. 4c,d), systematically changed these to match the consensus, then
analyzed splicing by RT-PCR (Supplementary Fig. 4e). The modified intron acceptor and
intron 1+lox template gave mixed products (Supplementary Fig. 4f); one of these was the
expected sequence, and the other was identical to ChR2 sequence 139 bp 5’ to the expected
splice site--likely revealing a cryptic splice site. Modification of either the exon or intron
donor sequences produced a single, expected product, yet only the optimized intron donor
sequence improved functional expression (ChR2-eYFP: 1316±120 pA n=8, intron donor:
2219±258 pA n=6, p<0.05, Fig. 2g, Supplemental Fig. 4g). We included this modification in
all constructs using intron 1.
We next combined recombinases (Cre/Flp) and engineered introns, using the DIO strategy to
independently manipulate ORF fragments. To target cells expressing Flp AND Cre (Fig. 3a),
we inserted cDIO recombinase recognition cassettes in both introns and fDIO cassettes
before and after the ChR2-eYFP coding sequence. Flp controlled direction of the entire
ORF, while the second exon was additionally controlled by Cre (Fig. 3b,c). Here, we paired
loxN22 with lox2722, and F317 with F5 (Supplementary Fig. 7), eliminating LoxP and FRT
to prevent trans recombination23 with legacy recognition sites in some transgenic animals.
We configured the first and third exons in the antisense direction, reversing their order, and
left the second in the sense direction (Con/Fon-ChR2-eYFP; Fig. 3b, Supplementary Fig. 8a).
Here, both recombinases are necessary to place all three exons into the sense configuration
(Fig. 3c) and either recombinase alone cannot produce a complete reading frame for ChR2
or eYFP.
To assess splicing, we prepared cDNA from HEK293 cells co-transfected with Cre, Flp, and
the Con/Fon-ChR2-eYFP construct. A shift in band size between transfected DNA and
cDNA was readily apparent (Fig. 3d); splicing was confirmed by sequencing (Fig. 3e). To
assess functionality and specificity, we co-transfected cultured neurons or HEK293 cells
with combinations of recombinases and Con/Fon-ChR2-eYFP. eYFP expression was only
observed in neurons co-expressing both Cre and Flp (Fig. 3f, Supplementary Fig. 8a),
consistent with population flow-cytometry data in HEK293 cells (Fig. 3g). Neurons
expressing Cre, Flp, and either ChR2-eYFP or Con/Fon-ChR2-eYFP had comparable
photocurrents (Fig. 3h) and light-evoked action potentials (Fig. 3i). To examine functional
specificity, we patched cells blinded to ChR2 expression and based solely on recombinase
expression (Supplementary Fig. 9a-c) and found photocurrents only in the triple-transfected
condition (Supplementary Fig. 9d,e). Last, we assessed the impact of expressing non-active
configurations of Con/Fon-ChR2-eYFP (Supplementary Fig. 10a) and observed no
deleterious effects on membrane properties (Supplementary Fig. 10b,c) or cell survival
(Supplementary Fig. 10d). These data indicate that integrating multiple recombinases with
heterologous introns is a viable strategy for intersectional expression dependent on Cre and
Flp recombinases, with expression levels comparable to native, intron-free, non-
recombinase-dependent counterparts. We term this system INTRSECT to describe its
underlying principles: INTronic Recombinase Sites Enabling Combinatorial Targeting.
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Function of Cre AND Flp dependent ChR2-eYFP in vivo
We next tested our intersectional expression strategy in vivo. We bred double-transgenic
Parvalbumin (PV)-p2A-Cre;Somatostatin (SOM)-IRES-Flp mice and injected WT, -Cre, -
Flp, or -Cre;-Flp mice with AAV-DJ-Con/Fon-ChR2-eYFP driven by the human Synapsin
(hSyn) or EF1α/HTLV (nEF) promoters in dorsal CA1 of hippocampus and mPFC. Rodent
CA1 contains PV+/SOM-, PV-/SOM+, and PV+/SOM+ neurons24, while mPFC lacks PV
+/SOM+ cells25. With imaging maximized for sensitivity and positive cells defined by
fluorescence above background, hippocampal expression was restricted to double-transgenic
Cre/Flp animals, regardless of promoter (nEF: 6.5 cells per slice, n=37 slices from 4
animals; hSyn: 8.2 cells per slice, n=52 slices from 3 animals). WT, PV-Cre, and SOM-Flp
animals displayed less than 1 cell per slice with fluorescence above background (Fig. 4), and
no expression was observed in mPFC (not shown).
We next analyzed ChR2 functionality in slices prepared from PV-p2a-Cre; SOM-IRES-Flp
animals injected with AAV-DJ-Con/Fon-ChR2-eYFP driven by either hSyn or nEF. Using
whole-cell patch-clamp with biocytin-filled pipettes (Fig. 4b), we found robust
photocurrents that reliably drove action potentials (Fig. 4c,d). To characterize the identity of
recorded cells, we stained for PV, SOM, and biocytin (Fig. 4e,f). Surprisingly, while all cells
expressed SOM, only 8/27 were positive for PV and even these were weakly stained. Since
some PV+/SOM+ cells are known to express only minimal PV26,27, we additionally
processed slices for morphological characterization28. Of cells that were recovered with
identifiable processes within the slice (17/33), 14/17 were classified as OLM and the
remaining 3/17 as bi-stratified (Fig. 4e,f); cell types known to express both PV and SOM28.
To further characterize cells expressing Con/Fon-ChR2-eYFP, we stained and imaged thin
slices and obtained data consistent with slice patching: most Con/Fon-ChR2-eYFP-
expressing cells examined were immunohistochemically SOM(+)/PV(lo/-) but were only
present in PV+/SOM+ animals (Fig. 4g-j). Recombinase transgene expression need not be
restricted to cells readily identifiable by immunostaining29; we therefore crossed a separate
PV-IRES-Cre mouse30 with SOM-IRES-Flp. Con/Fon-ChR2-eYFP expression was again
limited to -Cre;-Flp double transgenic mice (5.2 cells/slice, n=33 slices), although with
diminished fluorescence. Unlike PV-p2a-Cre;SOM-IRES-Flp mice, expression was largely
restricted to immunohistochemically PV+/SOM+ positive cells (87% of cells PV+/SOM+,
n=173 cells, Fig. 4k,l). Divergent expression of Con/Fon-ChR2-eYFP in these double-
transgenic mice is therefore likely driven by differences between the PV-p2a-Cre and PV-
IRES-Cre transgenic lines themselves.
INTRSECT-based exclusion targeting: AND NOT
This modular intron and recombinase targeting strategy potentially facilitates additional
expression logic through reorientation of exons within the standard backbone. We next
sought to target cells expressing recombinase X AND NOT recombinase Y (Con/Foff,
Coff/Fon; Fig. 5a-left) by manipulating starting directions of exons (Fig. 5a-right, 5b,
Supplementary Fig. 8b,c). We analyzed splicing in HEK293 cells and observed a large shift
in cDNA amplicon size relative to transfected DNA (Fig. 5c) and confirmed successful
splicing by sequencing (Fig. 5d). Neurons co-transfected with AND NOT constructs express
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ChR2-eYFP in the presence of the single activating recombinase but not with both Cre and
Flp (Figs. 5e,f, Supplementary Fig. 8b,c), consistent with flow cytometry population data
(Fig. 5g). These constructs exhibited comparable peak photocurrents (Fig. 5h) that drove
action potentials (Fig. 5i). We noted that Con/Foff-CY had a depressed photocurrent vs. non-
recombinase-dependent ChR2-YFP; unlike Con/Fon or Coff/Fon, this construct contains a full
recombinase cassette when active, with two ATG sequences in the spacer (Supplementary
Fig. 11a), but scrambling these improved photocurrents (Supplementary Fig. 11b). We
conclude from these results that multiple Boolean logical operations governing expression of
a single genetically encoded tool may be achieved using INTRSECT through simple
manipulation of a standard construct.
Projection targeting using multiple recombinases
We next combined fDIO and cDIO with projection-targeting strategies, in order to restrict
expression to cells defined by both genetic identity and projection pattern. Targeting
dopaminergic (DA) cells of the ventral tegmental area (VTA) projecting to nucleus
accumbens (NAc) requires an intersectional strategy as neither all VTA-DA neurons (which
project to numerous downstream areas) nor the entire VTA-NAc projection (which includes
DA and non-DA cells31) describes this population. We confirmed that projection-based
targeting alone was insufficient by injecting a retrograde virus, LT-HSV-mCherry-IRES-Cre
(Figs. 6a, Supplementary Fig. 13a-d), into NAc, and AAV-cDIO-ChR2-eYFP into VTA of
wild-type mice (Fig. 6b); only 48% of VTA eYFP+ cells were TH+ (Fig. 6c,d). To target
DA VTA-NAc neurons, we injected LTHSV-lox-STOP-lox-mCherry-IRES-Flp into NAc of
TH-Cre transgenic mice and AAV5-fDIO-ChR2-eYFP into VTA (Fig. 6e). Only VTA
neurons that both express Cre (TH+) and are transduced by LT-HSV (NAc-projecting)
should express Flp, and therefore activate fDIO-ChR2-eYFP. Indeed, 94% of VTA eYFP+
cells were clearly mCherry+ and 93% of VTA eYFP+ cells were TH+; 60% of mCh+/TH+
cells were eYFP+ (Fig. 6f,g). eYFP+ fibers were abundant in NAc (Fig. 6f), but absent in
mPFC and basolateral amydala (BLA), as expected32. Occasional sparse eYFP+ fibers but
no cell bodies were seen in negative controls lacking either Cre (WT mice; Supplementary
Fig. 14a,b) or Flp (no LT-HSV injection; Supplementary Fig. 14c,d).
Extension of INTRSECT
Other applications, such as expression of XFPs alone, require adaptation of these multiple-
recombinase tools to a single ORF; we achieved this by modifying the intron approach for
use with eYFP (Supplementary Fig. 12). Here, the 5’ and 3’ halves of eYFP are under
control of separate recombinases, with a single intron containing Cre and Flp DIO cassettes
(Supplementary Fig. 12a,b). RT-PCR analysis using direction-specific primers suggested
that eYFP sequence in Con/Fon, Con/Foff, and Fon/Coff variants was amplified from
recombinase co-transfected HEK293 cells, but not source DNA (Supplementary Fig. 12c,d)
and was verified by sequencing (Supplementary Fig. 12e). Flow cytometry indicated that
eYFP was only expressed after co-transfection with appropriate recombinases, including
AND NOT configurations at the analysis timepoint five days post-transfection
(Supplementary Fig. 12f).
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The modular design of INTRSECT opens the door to additional logical operations, including
XOR, NAND, and others (Supplementary Fig. 15). As criteria differentiating cell types
become more sophisticated, three-term Boolean logic may become desirable (e.g. a AND b
AND c), heightening the value of identifying new recombinases; for example, Cre relatives
VCre and SCre33. In preliminary work, we synthesized human codon-optimized VCre and
SCre, created vcDIO- and scDIO-ChR2-eYFP vectors, and transfected these alongside Cre,
Flp, and Dre in HEK293 cells (Fig. 6h). While scDIO/SCre did not function well, VCre
induced robust eYFP expression in vcDIOChR2-eYFP without cross-activity (Fig. 6h).
Discussion
In defining the function of specific cell types, precise targeting has been a long-standing
limitation, with expression of genetically-encoded tools generally constrained to populations
defined by a single feature. To meet challenges of multi-feature targeting, we have
developed and validated a flexible, modular, and generalized approach integrating multiple
recombinases, intron engineering, and specialized viruses (INTRSECT). While separability
of key recombinase pairings was seen here, contrary to previous reports of Cre/Dre
independence16 we observed Cre/Rox cross-reaction in vitro and in vivo. Cre and Dre are
both phage-derived, with recognition sites sharing high homology in the 13bp palindromic
region that determines recombinase pairing. Sites used here could contribute to this cross-
reaction and other non-canonical sites may allow for their combined use. In any case, our
results with Flp buttress independence from Cre, and establish this property for the first time
with Dre.
The multiple-recombinase and viral methods used in INTRSECT may synergize with
strategies for tracing connectivity across networks, such as engineered viruses34. It will be
important to validate penetrance, specificity, and safety of viral tools in each system. In this
regard, while we observed minimal inappropriate expression with our payload/virus
combinations, AAVs can form end-to-end concatamers with payload deletion and
rearrangement35, a process that may induce expression in isolation36 and could contribute
(along with low TH expression) to the small population of TH-negative cells in projection-
targeting experiments (Fig. 6f,g). Alternatively, read-through in HSV lox-stop-lox cassettes
is possible, separate from INTRSECT constructs7,10, and may be improved by alternative
strategies (Supplementary Fig. 16a). However, absence of inappropriate expression in
controls (Supplementary Fig. 14) suggests instead that targeting NAc-projecting cells may
enrich for rare VTA TH- cells labeled by this transgenic line8,32.
To create a single-AAV-based system capable of performing diverse Boolean logic on
expression patterns, we built upon a substantial intron literature. Pioneering work adding
heterologous introns to mammalian transgenes revealed that introns may function as
independent units and that their addition to cDNAs can improve expression in vitro20,37 and
in vivo38, consistent with our findings that introns inserted into ChR2-YFP are spliced and
enhance photocurrents. The design and use of intron-containing fluorophores may facilitate
integrating introns into genetic tools for increased expression. We relied on splice site
descriptions18,19 in optimizing INTRSECT constructs and found improved splicing
correlated with increased photocurrents, emphasizing potential benefits of heterologous
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introns. For future work requiring additional introns many options exist, although it may be
sufficient to duplicate these two39.
We tested the INTRSECT Con/Fon-ChR2 variant by producing double-transgenic PV-p2a-
Cre;SOM-IRES-Flp mice with populations of inhibitory neurons expressing only Cre (PV;
axo-axonic and basket cells), only Flp (SOM; hippocampal projection neurons), or both
Cre/Flp (PV;SOM O-LM and bi-stratified neurons)24. We observed robust expression within
hippocampus of double-transgenic animals, but not single-transgenic or wild-type animals,
nor in mPFC, consistent with PV and SOM expression patterns25. Additional experiments
are indicated to characterize behavioral roles of these cells that are now targetable, and
together with Con/Foff and Coff/Fon, these reagents may be of immediate utility in studies of
interneuron modulation of hippocampal function27.
Validation of targeting in each system with multiple approaches is indicated. Here, we used
IHC and morphologic analysis of targeted O-LM and bi-stratified hippocampal cells;
electrophysiological and other properties may also be employed. Differences observed in
targeted cell types between similar transgenic mouse lines underscores the importance of
considering recombinase expression pattern in transgenic animals, including bicistronic
knock-ins. Production of additional transgenic animals expressing Flp will augment options
for targeting refined cell populations.
Individual components of the INTRSECT system, including viral, recombinase, and intron
tools, may be separated or combined, as we have shown in targeting the NAc-projecting DA
cells of the VTA. Beyond this example, cells in an “upstream” brain region that project to
two different downstream regions could be targeted to either include or exclude neurons
based on projection pattern (Supplementary Fig. 16a,b) and may be combined with
transgenic recombinase mouse lines for additional specificity (Supplementary Fig. 16c).
And while we have used ChR2-eYFP as a single targeted gene here, these tools also enable
independent targeting and manipulation of multiple separately defined cell types within a
single animal (Supplementary Fig. 16d). INTRSECT tools have a modular design, may be
integrated with existing reagents and animals, and may enable diverse expression logic for
genetically-encoded tools based on multiple genetic and/or connectivity factors.
METHODS
Statistical Analysis
All statistical tests were chosen based on normality of data and appropriateness of
comparison to be analyzed by a particular approach. Data that were not normally distributed
were either transformed to achieve normality, or analyzed with a test that does not assume
normal distribution. Estimation of variance was performed by Bartlett's test for equal
variance (for ANOVAs) or by an F test to compare variance (for unpaired t-tests). Variances
were equal except when explicitly noted, below.
All error bars reported as s.e.m.
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Fig. 2e. n = 19 for ChR2-eYFP group, n = 12 for intron 1 group, n = 5 for intron 1+lox
group, n = 12 for intron 2 group, n = 5 for intron 2+lox group, n = 5 for intron 1+2 group.
One-way Type I ANOVA detected significant difference between the means: F5,52 = 2.856,
p = 0.0237. ChR2 and intron 2+lox showed significant differences: p<0.01, Dunnett's
multiple comparison test.
Fig. 2g. n = 8 for fSyn-ChR2-eYFP group, n = 5 for intron 1+lox group, n = 6 for iC4A
group (“intron 1+lox optimized”). fSyn-ChR2-eYFP and iC4A showed significant
differences: p<0.05, Dunnett's multiple comparison test.
Fig. 3h. n = 13 for ChR2 group, n = 7 for Con/Fon group. Unpaired two-sided t-test showed
no significant difference: p=0.1110.
Fig. 5h. n = 7 for fSyn-ChR2-eYFP group, n = 7 for Con/Fon group, n = 7 for Con/Foff group,
n = 6 for Fon/Coff group. One-way Type I ANOVA detected significant difference between
the means: F3,23 = 3.553, p = 0.0301. No significant differences were detected by Dunnett's
multiple comparison tests.
Molecular cloning
All single recombinase-dependent plasmids were constructed in an AAV-Ef1α backbone
using the double-floxed inverted open-reading-frame (DIO) strategy described previously7,8.
To construct Flp-dependent recombinant AAV vectors, a DNA cassette carrying two pairs of
incompatible FRT sites (FRT and F517) was synthesized and the ChR2-eYFP transgene was
inserted between the two sites in the reverse orientation. The resulting cassette was cloned
into a modified version of the pAAV2-MCS vector carrying the Ef1α promoter and the
Woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) to enhance
expression. A similar strategy was used to construct the Dre-dependent plasmids, except
since there was only one known Rox site16, a novel Rox site (‘Rox2’) was designed (5’ –
aactttaaataatgtcgattatttaaagtta – 3’).
Three constructs were used to deliver Cre into cells either in vivo or in vitro: AAV-Ef1α -
Cre, AAV-Ef1α -Cre-p2A, AAV-EF1α -mCherry-IRES-Cre. The p2A peptide sequence was
added where indicated as an immunostaining antigen. Similar constructs were used for Flp,
Dre, VCre, and SCre. Dre, VCre, and SCre were human codon optimized and synthesized
(DNA2.0, Mountain View, CA). All AAV vectors were tested for in vitro expression prior
to viral production. Updated maps are available at optogenetics.org.
To create early multiple recombinase dependent constructs, we used two separate
approaches to modifying cDIO-hChR2(H134R)-eYFP. First, by inverting the Ef1a promoter
and flanking it with (5’ of the promoter) FRT and F5 in the forward direction and (3’ of the
promoter) F5 and FRT in the reverse direction. This construct effectively has two tandem
DIO cassettes: one that encompasses the promoter and one that encompasses the ORF; thus
was named “Double Inverted Promoter/Double Inverted ORF (DIP/DIO)’ AAV-fd DIP
Ef1a-cd DIO hChR2 (H134R)-eYFP. Second, three other Cre and Flp dependent variants
were created by leaving the promoter in the forward direction, but nesting Flp recognition
sites such that the 5’ forward direction sites were within one of the extracellular loops of
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ChR2, while the 3’ reverse direction sites were situated beyond the STOP codon. The
portion of the ChR2 reading frame within the Flp recognition sites is initially in the forward
direction, while the portion of the reading frame under control of only Cre is initially in the
reverse direction. This second strategy retains a F5 site within the coding frame of ChR2 in
the active conformation that occurs after the recombination catalyzed by Cre and Flp.
Short introns identified by a literature search (Intron 1: CMV Towne Variant intron B20
genbank M60321, Mouse IgE intron 321 genbank X01857.1) and derivatives were
synthesized as oligos and inserted by overlapping PCR directly into the open reading frame
of ChR2 or eYFP as indicated. Target sites for insertion were determined using two criteria:
first, that the two bases 5’ and the two bases 3’ of the insertion site match the exonic 5’ and
3’ consensus splice site sequences, respectively; and second, that it would be unlikely that
either fragment upstream or downstream of the reading frame translated in isolation would
encode a functional protein. Splicing was tested in silico using NetGene240 (http://
www.cbs.dtu.dk/services/NetGene2/). To test intron function, these modified ChR2-eYFP
fusion genes were inserted into a lentiviral backbone driven by the human synapsin (hSyn)
promoter between BamHI and EcoRI, scaled up and purified using endotoxin-free (Qiagen
endotoxin-free MaxiPrep) or low endotoxin (Invitrogen MaxiCard) plasmid preparation kits
for small batch lentiviral production.
To introduce recombinase recognition sites and enable directional control of individual
exons, we first constructed a standard AAV backbone with a multiple cloning site
downstream of either the hSyn or chimeric EF1 α/HTLV promoter consisting (from 5’ to 3’)
of BamHI | AscI | SalI | SpeI | KpnI | NheI | XbaI | EcoRI through oligo ligation. We next
identified likely donor, branch point, and acceptor regions in the intron by comparison to
consensus sequences18,19. To ensure proper exon/exon joining, the donor and acceptor
sequences for each intron were directly joined to their exonic partners, using overlapping
PCR, without intervening restriction sites. To incorporate Flp control of all three exons,
incompatible sites17 F3 and F5 were separated by a short spacer sequence8 and placed
between BamHI and AscI in the sense direction and between XbaI and EcoRI in the
antisense direction. To incorporate Cre control of the second exon, incompatible sites22
Lox2722 and LoxN were separated by the same spacer sequence and fused in the sense
direction to the CMV (intron 1) bp and intronic sequence and in the antisense direction to
the IgE (intron 2) bp and intronic sequence and placed between the SalI and SpeI and KpnI
and NheI sites, respectively. F3 and LoxN were chosen over FRT and LoxP to decrease the
possibility of chromosomal translocation23 in transgenic animals that harbor either of these
sites in their genome as legacy sequence from antibiotic resistance cassettes used during
animal production. With this standard acceptor vector, exon direction for each Boolean
value was determined, correct restriction sites were placed on exons via PCR addition, and
exons were ligated into the AAV acceptor vector. DNA was amplified as above for
production of AAV. All constructs are freely available (www.optogenetics.org).
Construct variants for control experiments were built as follows: truncated ChR2 for exon
function experiments were created by 1) fusing the 3’ end of the exon 1 in-frame to eYFP,
adding bases as necessary and 2) fusing the 3’ end of the ChR2 portion of exon 2 to eYFP,
adding an ATG start codon to the 5’ end and bases as necessary to the 3’ end to create a
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functional reading frame. Constitutive blue fluorescent protein (BFP) was added to
constructs for cell health experiments by 1) creating a BFP expression cassette consisting (5’
to 3’) of the hSyn promoter, BFP, and polyA tail. This was then cloned into a unique MluI
site 5’ of the hSyn promoter driving expression of cDIO-ChR2-eYFP, fDIO-ChR2-eYFP, or
Con/Fon-ChR2-eYFP such that it was independently expressed from the recombinase-
dependent expression cassette.
Flow Cytometry
HEK 293FT cells (Invitrogen) were grown in 24-well tissue culture plates to 90%
confluence and transfected in duplicate with 800 ng total DNA with Lipofectamine 2000
(Invitrogen) following the manufacturer protocol. Five days post-transfection, cells were
removed by enzymatic dissociation (TrypLE, GIBCO), re-suspended in PBS, pelleted at 200
g × 5 min and re-suspended in 500 μL PBS supplemented with 1 μg/mL propidium iodide
(PI; Sigma) then placed on ice under aluminum foil until analysis. Flow cytometry was
completed on a Scanford analyzer at the Stanford Shared FACS Facility using settings
optimized for Side Scatter (SS), Forward Scatter (FS), PI, and eYFP acquisition using
positive (ChR2-eYFP), negative (empty transfection) and dead (heat-killed; 95 C × 3 min)
conditions as controls. Live cell populations used in comparisons were isolated from debris
and dead cells in post-hoc analysis by 1) negatively gating for PI+ cells, 2) positively gating
for the high-density population in plotting FS vs. SS.
To unambiguously assess the expression of ChR2-eYFP in our samples, we subsampled
each 30,000 point dataset into 100 independent datasets. The log-fluorescence (eYFP
intensity) of each of these 100 subsets was then independently fit to a multi-component
Gaussian mixture model that chose whether the dataset was best fit by one or more than one
curve, using the Bayesian information criterion to generate an accurate statistical estimate of
the distinct subpopulations best accounting for each set of observations.
Animals
Adult wild-type, male and female transgenic Parvalbumin-IRES-Cre30 (Jax 008069),
Parvalbumin-2a-Cre29 (Jax 012358), Tyrosine Hydroxylase-Cre (EMMA 00254), and
Somatostatin-Flp C57/BL6 mice were group housed up to four to a cage and kept on a
reverse 12 hour light/dark cycle with ad libitum food and water. Experimental protocols
were approved by Stanford University IACUC and meet guidelines of the National Institutes
of Health guide for the Care and Use of Laboratory Animals.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Diversifying recombinase targeting strategies
a) Recombinase recognition site sequences used in Double Inverted Open reading frame
(DIO) constructs. b) Schematic of recombinase-mediated expression of a DIO construct.
The ORF is initially inverted relative to the promoter and flanked by two sets of
incompatible recombinase recognition sites. The recombinase first inverts the gene of
interest into the forward orientation then either returns the gene to the starting position or
excises two recognition sites and locks the gene in the forward orientation. c) HEK293 cells
transfected with recombinase/DIO combinations. Arrowheads indicate Cre/Dre cross-
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reactivity. d) Flow cytometry analysis of cells from c. Dot plot (top) and histograms
(bottom) include biological replicates and controls. DIOs in isolation were comparable to
negative control (92%-98% of samples fit by single curve) and were robustly expressed
when paired with correct recombinase (99%-100% of samples fit by multiple curves). Cross-
reaction was noted between Cre and Dre (multiple populations fit in 78% and 92% for cDIO
+ Dre, 100% for dDIO + Cre; arrowheads), but not Flp (96%-100% of samples fit with
single curve). e) Viruses used in f-h. Each DIO was injected into mouse hippocampus alone
or with a recombinase. f,g) Recombinase/DIO expression in vivo at low (f) or high (g)
magnification. No leak was visible in absence of recombinase, and correct recombinase/DIO
pairs were expressed well. Sparse expression was seen with dDIO + Cre (arrowheads;
Supplementary Fig. 1; imaging individually optimized). h) In vivo optrode recordings in
animals co-injected with proper recombinase/DIO pairings.
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Figure 2. Intron engineering and validation for INTRSECT
a) Schematic of constructs and nomenclature. ‘empty’ denotes native introns, ‘lox’ indicates
addition of lox2722 site (see methods). b) cDNA was prepared from mRNA of HEK293
cells transfected with indicated constructs. Source DNA and cDNA were amplified by PCR
with primers (top) in either exons 1 and 2 (‘F1/R1’) or exons 2 and 3 (‘F2/R2’) and
separated by gel electrophoresis (bottom). Note that non-spliced DNA bands containing
introns vary in size, while cDNA bands from spliced mRNA are uniform. c) Sequence of
DNA isolated from bands in b, with uniform removal of intron sequence with these primer
sets. d) Images of eYFP expression in primary neuronal cultures transfected with indicated
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constructs. e) Whole cell photocurrents from primary neurons transfected with intron
constructs (ChR2-eYFP: 1422.1±91.7 pA n=19, intron 1: 1590.5±186.7 pA n=12, intron 1 +
lox: 1721.7±97.8 pA n=5, intron 2: 1861.6±159.1 pA n=12, intron 2 + lox: 2279.1±246.9
pA n=5, intron 1 + intron 2: 1539.5±188.8 pA n=5, p<0.01 Dunnett's multiple comparison
tests ChR2-eYFP vs. intron 2 + lox). All error bars s.e.m. f) Representative images of eYFP
expression in medial prefrontal cortex of mouse brain at 2 weeks post-infection timepoint
with lentivirus made from indicated constructs (see Supplementary Figure 6 for full dataset).
g) Whole cell photocurrents illustrating increased peak photocurrent activity after intron 1
optimization (ChR2-eYFP: 1316±120 pA n=8, intron 1 + lox2722: 1603±236 pA n=5,
intron donor: 2219±258 pA n=6, p<0.05 Dunnett's multiple comparison tests, ChR2-eYFP
vs. intron donor; see Supplementary Figure 4).
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Figure 3. INTRSECT: diverse recombinases with engineered introns enable intersectional
targeting in vitro
a,b) Schematics representing (a) cells targeted by nesting Cre-dependent directional control
of a central exon and Flp-dependent directional control of all three exons (b top), such that
both recombinases are necessary for all exons of the construct (Con/Fon-ChR2-eYFP) to be
in the sense direction (b bottom). c) Intermediate configurations in the activation of Con/Fon-
ChR2-eYFP. d) cDNA prepared from HEK293 cells transfected with indicated constructs
and recombinases and source DNA were amplified using primers in exons 1 and 3 and
separated by gel electrophoresis. Note size difference in bands from intron-containing DNA
and uniformity of cDNA bands, suggesting successful splicing. e) Sequences of bands from
d. Yellow denotes difference from ChR2-eYFP map sequence, representing intron sequence.
f) eYFP is only expressed in the presence of both Cre and Flp in cultured neurons
transfected with Con/Fon-ChR2-eYFP (green), Cre (blue), and Flp (red) (see Supplementary
Fig. 8). g) Flow cytometry dot plot (top) and biological replicate histograms (bottom) of
HEK293 cells transfected with indicated recombinase/construct combinations. YFP
expression is only seen with Con/Fon-ChR2-eYFP and both Cre and Flp (arrowheads; 100%
of norecombinase, Cre-alone, and Flp-alone transfections fit by a single curve, 100% of
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Cre/Flp co-transfections fit by multiple curves). h,i) Whole cell photocurrents (h) and action
potentials (i) recorded from primary neurons transfected with ChR2-eYFP or Con/Fon-ChR2-
eYFP and Cre/Flp indicate robust ChR2 function comparable to native ChR2 (ChR2-eYFP:
1120±187 pA, n=6, Con/Fon-ChR2-YFP: 1621±157 pA, n=7 p=0.3542: two-sided unpaired
t-test); all error bars s.e.m.
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Figure 4. INTRSECT specificity and functionality in vivo
a) Hippocampal slices prepared four weeks after SOM-IRES-Flp (left), PV-2a-Cre (middle),
or PV-2a-Cre;SOM-IRES-Flp (right) animals were injected with AAV-DJ-Con/Fon-ChR2-
eYFP. Expression was only seen in double transgenic animals, with eYFP+ cell bodies
limited to the superficial hippocampus (so: stratum oriens; sp: stratum pyramidale; sr:
stratum radiatum; slm: stratum lacunosum-moleculare). b-d) eYFP+ cells in PV-2a-
Cre;SOM-IRES-Flp animals expressing Con/Fon-ChR2-eYFP were patched with biocytin
filled pipettes (b), and assayed for peak photocurrent (c) and action potentials (d). e-f) After
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patching, slices were stained for biocytin (grey), PV (blue), and SOM (red) for identification
(e,f left), followed by morphological reconstruction (e,f right). All error bars s.e.m. All
identified neurons were either O-LM (e) or bi-stratified (f) and stained SOM(+), but
apparently PV(lo/-) and were therefore identified largely based on their morphology. g-j) To
characterize more thoroughly the cells targeted in PV-2a-Cre;SOM-IRES-Flp animals by
Con/Fon-ChR2-eYFP, slices from wild type, PV-2a-Cre, SOM-IRES-Flp, and PV-2a-
Cre;SOM-IRES-Flp animals injected with virus driven by either hSyn or nEF were stained
for SOM and PV. YFP+ cells driven by both nEF (g,h) and hSyn (i,j) stained SOM(+), but
PV(-) (g,i; arrowheads). Imaging settings optimized for sensitivity detected negligible
inappropriate expression in all but a single of 11 control animals, while double transgenic
animals had high levels of expression (h,j). k,l) To examine the contribution of transgenic
lines on virus expression, nEF-Con/Fon-ChR2-eYFP was injected into dorsal CA1 of PV-
IRES-Cre;SOM-IRES-Flp mice; despite relatively weak expression (k), YFP was almost
completely restricted to cells co-expressing PV and SOM (k,l; arrowhead).
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Figure 5. Exclusion logic using INTRSECT
a) Schematics representing target populations of cells expressing Cre and Flp (left) by
nesting Cre-dependent directional control of a central exon and Flp-dependent directional
control of all three exons (right). b) Intermediate states driven by Cre and Flp on constructs
dependent on the exclusive presence of a single recombinase for functional expression
(dashed box). c) cDNA prepared from mRNA of HEK293 cells transfected with indicated
constructs and recombinases and source DNA were amplified by PCR with primers in exons
1 and 3 and separated by gel electrophoresis. Note variation in the size of bands from intron-
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containing DNA template and uniformity of cDNA bands, suggesting successful splicing. d)
Sequences of bands from b. Yellow denotes differences from ChR2-eYFP map sequence,
representing intron sequence. e,f) eYFP is only expressed in cultured neurons transfected
with combinations of Cre (blue), Flp (red), and Con/Foff (e; green) or Coff/Fon (f; green) in
the exclusive presence of Cre or Flp. g) Dot exemplar (top) and replicate histograms
(bottom) of flow cytometry analysis of HEK293 cells transfected with indicated
recombinase/construct combinations indicates expression in the presence of a single
recombinase (arrowheads) that is extinguished when both recombinases are present, which
was confirmed by Gaussian mixture model analysis (multiple populations fit in 85%-96% of
matched single-recombinase transfections, single population fit in 94%-99% of double-
recombinase transfections). h,i) Whole cell photocurrents (h) and action potentials (i)
recorded from primary neurons transfected with ChR2-eYFP or Con/Fon, Con/Foff, Coff/Fon-
ChR2-eYFP and Cre and Flp as indicated. All error bars s.e.m.
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Figure 6. Combinatorial targeting with multiplexed recombinases: beyond genetic properties
a) Comparison of short-term (ST-HSV) and optimized long-term (LT-HSV) backbones. b)
Projection-based targeting of the NAc-projecting VTA cells in a wild-type mouse.
Retrograde LT-HSV-mCherry-IRES-Cre was injected into the NAc, while AAV-cDIO-
ChR2-eYFP was injected into the VTA. c,d) In vivo expression pattern observed with
projection-based targeting. Robust eYFP expression was observed within VTA, co-localized
with TH in only 48% (69/145) of cells, indicating expression in both dopaminergic and non-
dopaminergic VTA-NAc projection neurons. eYFP+ fibers were seen within the NAc. e)
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Schematic illustrating strategy for combination projection/genetic targeting of the NAc-
projecting TH+ VTA cells in a TH-IRES-Cre mouse. Cre-dependent Flp was packaged into
a retrograde LT-HSV and injected into the NAc, while AAV-fDIO-ChR2-eYFP was
injected into the VTA. f,g) In vivo expression pattern observed with combination projection/
genetic based targeting. eYFP expression in the VTA was highly co-localized with TH
staining (145/156 cells), indicating restriction of expression to dopaminergic VTA-NAc
projection neurons. eYFP+ fibers were seen within the NAc. h) Dot exemplar (top) and
replicate histograms (bottom) of flow cytometry analysis of HEK293 cells transfected with
indicated recombinase-dependent ChR2-eYFP constructs and recombinases indicate that
codon-optimized VCre is able to activate vcDIO in mammalian cells (100% of samples fit to
multiple curves) and does not cross-activate cDIO or fDIO (93%-98% of off-target DIOs fit
with single curve). Moreover vcDIO is not activated by Cre and Flp. Note again cross-
reaction between Cre/dDIO and Dre/cDIO. Specificity was quantitatively verified by
Gaussian mixture model fits/analysis.
Fenno et al. Page 26
Nat Methods. Author manuscript; available in PMC 2014 July 08.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
